ConductScience.org, home

Paper29889239

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.

Chu CS and 20 others. Clin Infect Dis, 2018. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria. Papers, record 29889239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29889239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2018
PubMed
Publication types
Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2024-03-15
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chu CSCindy S
2Phyo APAung Pyae
3Lwin KMKhin Maung
4Win HHHtun Htun
5San TThida
6Aung AAAye Aye
7Raksapraidee RRattanaporn
8Carrara VIVerena I
9Bancone GGermana
10Watson JJames
11Moore KAKerryn A
12Wiladphaingern JJacher
13Proux SStéphane
14Sriprawat KKanlaya
15Winterberg MMarkus
16Cheah PYPhaik Yeong
17Chue ALAmy L
18Tarning JJoel
19Imwong MMallika
20Nosten FFrançois

Source PubMed

See all 21 authorsDownload CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
ArtesunateMajor topic
ChloroquineMajor topic
Malaria, VivaxMajor topic
PrimaquineMajor topic
Adolescent
Adult
Child
Child, Preschool
Drug Therapy, Combination
Female
Humans
Infant
Male
Middle Aged
Myanmar
Parasitemia
Plasmodium vivax
Recurrence
Thailand
Treatment Outcome
Young Adult

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
089179/Z/09/ZWellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01074905Study on the Treatment of Vivax MalariaDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123472056Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.PLoS Med2013https://conductscience.org/library/papers/23472056PubMed
211716124Factors contributing to anemia after uncomplicated falciparum malaria.Am J Trop Med Hyg2001https://conductscience.org/library/papers/11716124PubMed
38133114Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.J Infect Dis1994https://conductscience.org/library/papers/8133114PubMed
426888075Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.Malar J2016https://conductscience.org/library/papers/26888075PubMed
626437860Malaria ecology along the Thailand-Myanmar border.Malar J2015https://conductscience.org/library/papers/26437860PubMed
710674098Treatment of vivax malaria on the western border of Thailand.Trans R Soc Trop Med Hyg1999https://conductscience.org/library/papers/10674098PubMed
821989376Determinants of relapse periodicity in Plasmodium vivax malaria.Malar J2011https://conductscience.org/library/papers/21989376PubMed
910817728Therapeutic responses to different antimalarial drugs in vivax malaria.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10817728PubMed
1012499187Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12499187PubMed
1118563961Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea.PLoS Med2008https://conductscience.org/library/papers/18563961PubMed
1218563962Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.PLoS Med2008https://conductscience.org/library/papers/18563962PubMed
1322002979Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.Clin Infect Dis2011https://conductscience.org/library/papers/22002979PubMed
1423782898The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.Malar J2013https://conductscience.org/library/papers/23782898PubMed
1522966124Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age.J Infect Dis2012https://conductscience.org/library/papers/22966124PubMed
1626654101Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.BMC Med2015https://conductscience.org/library/papers/26654101PubMed
1723254437Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23254437PubMed
1828170391Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.PLoS Med2017https://conductscience.org/library/papers/28170391PubMed
1925073652Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data.Malar J2014https://conductscience.org/library/papers/25073652PubMed
209230792Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels.Am J Trop Med Hyg1997https://conductscience.org/library/papers/9230792PubMed
2118046504Glucose-6-phosphate dehydrogenase mutations in Mon and Burmese of southern Myanmar.J Hum Genet2008https://conductscience.org/library/papers/18046504PubMed

See all 21 referencesDownload CSV of references

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
41960341Frequent and genetically diverse Plasmodium vivax relapses contribute to malaria transmission in Cambodia.Res Sq2026https://conductscience.org/library/papers/41960341PubMed
41541400Plasmodium vivax Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand.Open Forum Infect Dis2026https://conductscience.org/library/papers/41541400PubMed
41239453Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis.Malar J2025https://conductscience.org/library/papers/41239453PubMed
40518540Efficacy of chloroquine with primaquine for uncomplicated Plasmodium vivax malaria without G6PD testing in Northwest Ethiopia: a one-arm in vivo prospective therapeutic efficacy study.Malar J2025https://conductscience.org/library/papers/40518540PubMed
40420173Does mass chloroquine treatment have any role in the elimination of Plasmodium vivax ?Malar J2025https://conductscience.org/library/papers/40420173PubMed
40247375[Effect of low-dose primaquine treatment on Plasmodium vivax recurrence and transmission-blocking activity in southwest Ethiopia: a longitudinal cohort study.Malar J2025https://conductscience.org/library/papers/40247375PubMed
40152264Efficacy of Primaquine for the Radical Cure of Plasmodium vivax Malaria in Northeast Myanmar and the Impact of Cytochrome P450 2D6 Genotypes.Clin Infect Dis2025https://conductscience.org/library/papers/40152264PubMed
4011285214 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study.Lancet Infect Dis2025https://conductscience.org/library/papers/40112852PubMed
39820011A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border.PLOS Glob Public Health2025https://conductscience.org/library/papers/39820011PubMed
39332427Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.Lancet Child Adolesc Health2024https://conductscience.org/library/papers/39332427PubMed
39331646Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.PLoS Med2024https://conductscience.org/library/papers/39331646PubMed
39117628Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.Nat Commun2024https://conductscience.org/library/papers/39117628PubMed
38041857Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.J Infect Dis2024https://conductscience.org/library/papers/38041857PubMed
37817240Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.Malar J2023https://conductscience.org/library/papers/37817240PubMed
37748497Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.Lancet Infect Dis2024https://conductscience.org/library/papers/37748497PubMed
37748496Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis.Lancet Infect Dis2024https://conductscience.org/library/papers/37748496PubMed
36534705Population heterogeneity in Plasmodium vivax relapse risk.PLoS Negl Trop Dis2022https://conductscience.org/library/papers/36534705PubMed
36472067The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis.Elife2022https://conductscience.org/library/papers/36472067PubMed
36296297Molecular Profiles of Multiple Antimalarial Drug Resistance Markers in Plasmodium falciparum and Plasmodium vivax in the Mandalay Region, Myanmar.Microorganisms2022https://conductscience.org/library/papers/36296297PubMed
35739554Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report.Malar J2022https://conductscience.org/library/papers/35739554PubMed

See all 54 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
G6PD2539PubTator's text mininghttps://conductscience.org/library/genes/2539NCBI Gene
HBG23048PubTator's text mininghttps://conductscience.org/library/genes/3048NCBI Gene

Download CSV of genes

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
ARTESUNATECHEMBL361497Derived from the trial1https://conductscience.org/library/drugs/CHEMBL361497ChEMBL
PRIMAQUINECHEMBL506Derived from the trial1https://conductscience.org/library/drugs/CHEMBL506ChEMBL
CHLOROQUINECHEMBL76Derived from the trial1https://conductscience.org/library/drugs/CHEMBL76ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29889239

GET https://conductscience.org/api/papers/v1/29889239/authors?page=2